The new warnings about the GI drug Propulsid (cisapride)

August 1998

The new warnings about the GI drug Propulsid (cisapride) arecausing many physicians to switch to safer alternatives.

Lots of patients take Propulsid...over $1 billion is sold per year.

But it's causing serious arrhythmias and even somedeaths...especially in patients with predisposing factors, or oninteracting drugs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote